Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-104829
Filing Date
2022-10-03
Accepted
2022-10-03 06:02:51
Documents
3
Period of Report
2022-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2227219d1_6k.htm 6-K 9764
2 EXHIBIT 99.1 tm2227219d1_ex99-1.htm EX-99.1 17484
3 GRAPHIC image_003.jpg GRAPHIC 3166
  Complete submission text file 0001104659-22-104829.txt   32735
Mailing Address 5820 OBERLIN DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address 5820 OBERLIN DRIVE, SUITE 101 SAN DIEGO CA 92121 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 221285788
SIC: 2834 Pharmaceutical Preparations